Clinical trials
Observational Hematologic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 3 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Unknown status | 10 |
| Recruiting | 6 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 6 |
| Hospices Civils de Lyon | 3 |
| University Hospital, Caen | 3 |
| University Hospital, Toulouse | 3 |
| University Hospital, Strasbourg, France | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier de Cornouaille | 1 |
| European Society for Blood and Marrow Transplantation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 33 |
| Neoplasms | 7 |
| Leukemia | 3 |
| Lymphoma | 3 |
| Atrial Fibrillation | 2 |
| COVID-19 | 2 |
| Febrile Neutropenia | 2 |
| Multiple Myeloma | 2 |
| Neutropenia | 2 |
| Acute Kidney Injury | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.